The Lanham Act allows for the registration of trademarks in the United States and does not prohibit registration of a mark based solely on the prior registration of a similar mark in another jurisdiction. The Act does, however, provide for the cancellation of U.S. marks that misrepresent the source of the goods or services that are sold in connection with the U.S. mark. 15 U.S.C. §1064(3) (Section 14(3)). In Belmora v. Bayer Consumer Care AG, the U.S. Court of Appeals for the Fourth Circuit affirmed the Trademark Trial and Appeal Board's cancellation under Section 14(3) of Belmora's U.S. mark for its FLANAX pain-relief product sold in the United States, finding that "Belmora knew that the FLANAX mark was in use in Mexico [by Bayer] when it adopted the mark in the United States, copied Bayer's packaging, and 'repeatedly invoked' the reputation of Bayer's product in its marketing materials." 987 F.3d 284, 299 (4th Cir. 2021).